Rankings
▼
Calendar
MIRM Q3 2025 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MIRM
Mirum Pharmaceuticals, Inc.
$5B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$133M
+47.2% YoY
Gross Profit
$107M
80.8% margin
Operating Income
$3M
2.0% margin
Net Income
$3M
2.2% margin
EPS (Diluted)
$0.05
QoQ Revenue Growth
+4.1%
Cash Flow
Operating Cash Flow
$40M
Free Cash Flow
$39M
Stock-Based Comp.
$18M
Balance Sheet
Total Assets
$785M
Total Liabilities
$493M
Stockholders' Equity
$292M
Cash & Equivalents
$282M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$133M
$90M
+47.2%
Gross Profit
$107M
$70M
+54.5%
Operating Income
$3M
-$13M
+120.5%
Net Income
$3M
-$14M
+120.4%
Revenue Segments
Product
$133M
100%
Geographic Segments
UNITED STATES
$104M
78%
Rest Of World
$29M
22%
← FY 2025
All Quarters
Q4 2025 →